Robotic Microtool Control in an Intelligent Automated In Vitro Fertilization and Intracytoplasmic Sperm Injection Platform
US-2024426856-A1 · Dec 26, 2024 · US
US10215830B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10215830-B2 |
| Application number | US-201514971296-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 16, 2015 |
| Priority date | Dec 16, 2015 |
| Publication date | Feb 26, 2019 |
| Grant date | Feb 26, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods and systems for diagnosing cancer in the prostate and other organs are disclosed. Exemplary methods comprises extracting texture information from MRI imaging data for a target organ, sometimes using two or more different imaging modalities. Texture features are determined that are indicative of cancer by identifying frequent texture patterns. A classification model is generated based on the determined texture features that are indicative of cancer, and diagnostic cancer prediction information for the target organ is then generated to help diagnose cancer in the organ.
Opening claim text (preview).
The invention claimed is: 1. A method for facilitating cancer diagnosis, comprising: extracting texture information from imaging data for a target organ; determining texture features that are indicative of cancer by identifying frequent texture patterns in the extracted texture information by: (1) identifying frequent texture patterns from the extracted texture information using frequent pattern mining by: (a) identifying length-1 frequent patterns in the extracted texture information that are represented by a single texture pattern code that occurs more than a predetermined threshold percentage of the entire dataset, (b) examining sub-datasets of the extracted texture information, wherein each sub-dataset contains a different one of the identified length-1 frequent patterns, (c) generating frequent patterns with increasing pattern length, and (d) examining additional sub-datasets of the extracted texture information, wherein each additional sub-dataset contains a different one of the generated frequent patterns having the increased pattern length; (2) comparing occurrences of the frequent texture patterns between cancers and benign tissue using a Wilcoxon rank-sum test and selecting significant texture patterns based on the comparison; and (3) ordering the significant texture patterns using minimum redundancy maximum relevance (mRMR) criterion, and then choosing the most discriminative texture features using forward feature selection; generating a classification model based on the determined texture features that are indicative of cancer; and based on the classification model, generating diagnostic cancer prediction information for the target organ. 2. The method of claim 1 , wherein the imaging data is derived from high-b-value diffusion weighted MRI. 3. The method of claim 1 , wherein the imaging data is derived from T2-weighted MRI. 4. The method of claim 1 , further comprising extracting texture information from first imaging data for a target organ and second imaging data for the target organ, the first and second imaging data being derived from different imaging modalities. 5. The method of claim 4 , wherein the first imaging data is derived from high-b-value diffusion weighted MRI and the second imaging data is derived from T2-weighted MRI. 6. The method of claim 4 , further comprising normalizing and registering the first imaging data and the second imaging data prior to applying the classification model. 7. The method of claim 1 , wherein the extraction of texture information is performed using local binary pattern (LBP), local direction derivative pattern (LDDP), and variance measure operator (VAR). 8. The method of claim 1 , wherein the classification model is generated using support vector machine (SVM). 9. The method of claim 1 , wherein generating diagnostic cancer prediction information comprises generating a cancer prediction map for the target organ. 10. A computing system for cancer diagnosis, the system comprising a processor and memory, the system operable to: extract texture information from first imaging data for a target organ; based on the extracted texture information, determine texture features that are indicative of cancer by: identifying frequent texture patterns from the extracted texture information using frequent pattern mining by: (a) identifying length-1 frequent patterns in the extracted texture information that are represented by a single texture pattern code that occurs more than a predetermined threshold percentage of the entire dataset, (b) examining sub-datasets of the extracted texture information, wherein each sub-dataset contains a different one of the identified length-1 frequent patterns, (c) generating frequent patterns with increasing pattern length, and (d) examining additional sub-datasets of the extracted texture information, wherein each additional sub-dataset contains a different one of the generated frequent patterns having the increased pattern length; comparing occurrences of the frequent texture patterns between cancers and benign tissue using a Wilcoxon rank-sum test and selecting significant texture patterns based on the comparison; and ordering the significant texture patterns via minimum redundancy maximum relevance (mRMR) criterion; generate a classification model based on the determined texture features that are indicative of cancer; and based on the classification model, generate a diagnostic cancer prediction map of the target organ. 11. The system of claim 10 , wherein the first imaging data is derived from high-b-value diffusion weighted MRI. 12. The system of claim 10 , wherein the first imaging data is derived from T2-weighted MRI. 13. The system of claim 10 , wherein the system is operable to receive second imaging data for the target organ, the first and second imaging data being from different imaging modalities. 14. The system of claim 13 , wherein the first imaging data is derived from high-b-value diffusion weighted MRI and the second imaging data is derived from T2-weighted MRI. 15. The system of claim 13 , wherein the system is operable to normalize and register the first and second imaging data prior to extracting texture information. 16. The system of claim 10 , wherein the texture information is extracted using local binary pattern (LBP), local direction derivative pattern (LDDP), and variance measure operator (VAR). 17. The system of claim 10 , wherein the classification model is generated using support vector machine (SVM). 18. The system of claim 10 , wherein the target organ is a human prostate. 19. One or more non-transitory computer readable media storing computer-executable instructions, which when executed by a computer cause the computer to perform the method of claim 1 .
involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging · CPC title
by filtering or weighting based on different relaxation times within the sample, e.g. T1 weighting using an inversion pulse · CPC title
based on statistical description of texture · CPC title
Biomedical image inspection · CPC title
Diffusion imaging · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.